BiomeBank |
Adelaide, Australia |
Curated Gut Microbiomes for Disease Treatment |
Microba Life Sciences |
Brisbane, Australia |
Metagenomics Platform for Bacteriome Drug Discovery |
Microbiome Insights |
Richmond, BC |
Microbiome Analysis and Research |
Obulytix |
Gent, Belgium |
Phage lysin development |
MRM Health |
Ghent, Belgium |
Microbiotic Therapies |
Actym Therapeutics |
Berkeley, CA |
Microbial-based immunotherapy platform |
ResVita Bio |
Berkeley, CA |
Engineered Skin Probiotics |
Metagenomi |
Emeryville, CA |
Gene-Edited Microbial Treatments |
Siolta Therapeutics |
San Carlos, CA |
Gut Microbiome Modification |
Pragma Bio |
San Francisco, CA |
Microbial-derived small molecules |
SNIPR BIOME |
Copenhagen, Denmark |
CRISPR for microbiome management, genetically-modified bacteriophages |
Enterome |
Evry, France |
Microbiome-related diseases, diagnostics |
Biocodex |
Gentilly, France |
Microbiota Treatments |
MaaT Pharma |
Lyon, France |
Microbiome Correction |
Eligo Bioscience |
Paris, France |
Protein-based nanodelivery vectors, bacteriophages |
Enterome |
Paris, France |
Microbiome-related diseases, diagnostics |
ClostraBio |
Chicago, IL |
Food Allergy Treatments |
Realize Therapeutics |
Lake Bluff, IL |
Cannabinoid-based & Microbiotic Therapeutics |
BiomX |
Ness Ziona, Israel |
Microbiome-based Therapeutics |
Biomica |
Rehovot, Israel |
Microbiome Therapies |
CNCure Biotech |
Jeollanam, Korea |
Bacterial Platform for Developing Treatments, Radiotheranostics |
Kookmin Bio |
Jeonju, Korea |
Microbiome Research |
Kobiolabs |
Seongnam, Korea |
Microbiome Therapeutics |
GI Innovation |
Seoul, Korea |
Microbiome combination drug development |
Genome & Company |
Suwon, Korea |
Microbiome, Antibody Therapies |
Liveome |
Suwon, Korea |
Microbiome Therapeutics for Intractable Diseases |
DermBiont |
Boston, MA |
Topical Bacterial Products |
Finch Therapeutics |
Boston, MA |
Microbiological Therapy |
Concerto Biosciences |
Cambridge, MA |
Bacterial Skin Therapies |
GRO Biosciences |
Cambridge, MA |
Genetically altered bacteria for drug improvement |
Seres Therapeutics |
Cambridge, MA |
Microbial drugs to counteract antibiotic side effects |
Vedanta Biosciences |
Cambridge, MA |
Therapies that modulate pathways of interaction between the human microbiome and the host immune system |
Solarea Bio |
Waltham, MA |
Microbiome Treatments |
Axial Therapeutics |
Woburn, MA |
Neurology-Microbiome research |
MarvelBiome |
Woburn, MA |
Microbial Therapeutics |
ExeGi Pharma |
Rockville, MD |
Live Therapeutics |
Esperion Therapeutics (2) |
Ann Arbor, MI |
Bacteriome |
Symberix |
Durham, NC |
Small molecules that act upon human microbiome |
Locus Biosciences |
Morrisville, NC |
CRISP-engineered Bacteriophage Therapeutics |
Kanvas Biosciences |
Monmouth Junction, NJ |
Microbiome Drug Discovery |
Nubiyota |
Guelph, ON |
Microbiome therapeutics platform |
Lxbio Pharmaceuticals |
Lisbon, Portugal |
Bacteriophages, Antibody Fragment, Topical |
Pulmobiotics |
Barcelona, Spain |
Live Biotherapeutics |
Microviable Therapeutics |
Gijon, Spain |
Intestinal Microbiota Isolation Kit |
Telum Therapeutics |
Noáin, Spain |
Bacteriophages |
Infant Bacterial Therapeutics |
Stockholm, Sweden |
Premature Infant Treatments |
OM Pharma |
Meyrin, Switzerland |
Microbial derived immunotherapeutic products |
Redbiotec |
Schlieren, Switzerland |
Various Biologic Modalities |
Microbiotica |
Cambridge, UK |
Gut Bacteria Phenotype to Biomarker/Therapeutics |
EnteroBiotix |
Lanarkshire, UK |
Fecal microbiota transplantation |
Juno Bio Ltd. |
London, UK |
Vaginal Microbiome Health |
CHAIN Biotech |
Nottingham, UK |
Microbiome therapeutics |